Imricor Medical Systems, Inc. (ASX:IMR)
1.970
+0.040 (2.07%)
Aug 28, 2026, 4:10 PM AEST
Imricor Medical Systems Revenue
Imricor Medical Systems had revenue of $60.53K USD in the quarter ending June 30, 2026, a decrease of -7.11%. This brings the company's revenue in the last twelve months to $120.08K, down -83.96% year-over-year. In the year 2025, Imricor Medical Systems had annual revenue of $292.31K, down -69.53%.
Revenue (ttm)
$120.08K
Revenue Growth
-83.96%
P/S Ratio
4,069.73
Revenue / Employee
n/a
Employees
n/a
Market Cap
706.39M AUD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 292.31K | -667.12K | -69.53% |
| Dec 31, 2024 | 959.42K | 343.86K | 55.86% |
| Dec 31, 2023 | 615.57K | -200.44K | -24.56% |
| Dec 31, 2022 | 816.01K | 119.74K | 17.20% |
| Dec 31, 2021 | 696.27K | -5.89K | -0.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Cochlear | 2.35B |
| PolyNovo | 149.98M |
| SomnoMed | 118.50M |
| Saluda Medical | 114.04M |
| Aroa Biosurgery | 86.47M |
| Cyclopharm | 34.42M |
| Lumos Diagnostics Holdings | 19.07M |
| EBR Systems | 9.32M |
Imricor Medical Systems News
- 18 days ago - Imricor Medical Systems Earnings Call Transcript: H1 2026 - Transcripts
- 18 days ago - Imricor Medical Systems Earnings release: H1 2026 - Filings
- 18 days ago - Imricor Medical Systems Slides: H1 2026 - Filings
- 4 months ago - Imricor Medical Systems Transcript: AGM 2026 - Transcripts
- 4 months ago - Imricor Medical Systems Slides: FY 2026 - Filings
- 4 months ago - Imricor Medical Systems Slides: Investor presentation - Filings
- 4 months ago - Imricor Medical Systems Earnings release: Q1 2026 - Filings
- 6 months ago - Imricor Medical Systems Earnings Call Transcript: H2 2025 - Transcripts